175 related articles for article (PubMed ID: 20607366)
1. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.
Merino G; Perez M; Real R; Egido E; Prieto JG; Alvarez AI
Pharm Res; 2010 Oct; 27(10):2098-105. PubMed ID: 20607366
[TBL] [Abstract][Full Text] [Related]
2. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones.
Pérez M; Real R; Mendoza G; Merino G; Prieto JG; Alvarez AI
J Vet Pharmacol Ther; 2009 Oct; 32(5):498-502. PubMed ID: 19754918
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.
Perez M; Otero JA; Barrera B; Prieto JG; Merino G; Alvarez AI
Vet J; 2013 May; 196(2):203-8. PubMed ID: 23083838
[TBL] [Abstract][Full Text] [Related]
4. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.
Zhang Y; Wang H; Unadkat JD; Mao Q
Drug Metab Dispos; 2007 Dec; 35(12):2154-8. PubMed ID: 17785426
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice.
Álvarez AI; Vallejo F; Barrera B; Merino G; Prieto JG; Tomás-Barberán F; Espín JC
Drug Metab Dispos; 2011 Nov; 39(11):2008-12. PubMed ID: 21828252
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
[TBL] [Abstract][Full Text] [Related]
8. Identification of Food-Derived Isoflavone Sulfates as Inhibition Markers for Intestinal Breast Cancer Resistance Proteins.
Agustina R; Masuo Y; Kido Y; Shinoda K; Ishimoto T; Kato Y
Drug Metab Dispos; 2021 Nov; 49(11):972-984. PubMed ID: 34413161
[TBL] [Abstract][Full Text] [Related]
9. Effect of pregnancy on nitrofurantoin disposition in mice.
Zhang Y; Zhou L; Unadkat JD; Mao Q
J Pharm Sci; 2009 Nov; 98(11):4306-15. PubMed ID: 19422048
[TBL] [Abstract][Full Text] [Related]
10. N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.
Wang L; Leggas M; Goswami M; Empey PE; McNamara PJ
Drug Metab Dispos; 2008 Dec; 36(12):2591-6. PubMed ID: 18799806
[TBL] [Abstract][Full Text] [Related]
11. Modulation of monepantel secretion into milk by soy isoflavones.
Gunes Y; Okyar A; Krajcsi P; Fekete Z; Ustuner O
J Vet Pharmacol Ther; 2023 May; 46(3):185-194. PubMed ID: 36448496
[TBL] [Abstract][Full Text] [Related]
12. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
[TBL] [Abstract][Full Text] [Related]
13. The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.
Adkison KK; Vaidya SS; Lee DY; Koo SH; Li L; Mehta AA; Gross AS; Polli JW; Lou Y; Lee EJ
Br J Clin Pharmacol; 2008 Aug; 66(2):233-9. PubMed ID: 18429968
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.
Wright JA; Haslam IS; Coleman T; Simmons NL
Eur J Pharmacol; 2011 Dec; 672(1-3):70-6. PubMed ID: 22004608
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.
Yang Z; Zhu W; Gao S; Yin T; Jiang W; Hu M
Drug Metab Dispos; 2012 Oct; 40(10):1883-93. PubMed ID: 22736306
[TBL] [Abstract][Full Text] [Related]
18. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
19. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
[TBL] [Abstract][Full Text] [Related]
20. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2.
Wang X; Morris ME
Drug Metab Dispos; 2007 Feb; 35(2):268-74. PubMed ID: 17093006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
